Transact Technologies (TACT) Research & Development (2010 - 2026)

Transact Technologies has reported Research & Development for 17 years, with the latest figure at $2.2 million in Q1 2026.

• Quarterly Research & Development rose 5.37% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 11.27% YoY) and the FY2025 annual result came in at $6.7 million, down 4.27% from the prior year.
• Research & Development climbed to $2.2 million in Q1 2026 per TACT's latest filing, from $422000.0 in the prior quarter.
• Over five years, Research & Development peaked at $4.9 million in Q4 2022 and troughed at $422000.0 in Q4 2025.
• A 5-year average of $2.1 million and a median of $2.2 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 106.51% in 2022, then plunged 68.03% in 2023.
• Over 5 years, Research & Development stood at $4.9 million in 2022, then slumped by 68.03% to $1.6 million in 2023, then slumped by 46.22% to $840000.0 in 2024, then sank by 49.76% to $422000.0 in 2025, then jumped by 420.62% to $2.2 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $2.2 million, $422000.0, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.